Biomarker-guided classification scheme of neurodegenerative diseases

被引:18
|
作者
Baldacci, Filippo [1 ,2 ,3 ]
Lista, Simone [4 ,5 ,6 ]
Garaci, Francesco [7 ,8 ]
Bonuccelli, Ubaldo [1 ]
Toschi, Nicola [7 ,9 ,10 ]
Hampel, Harald [2 ,3 ,4 ,5 ]
机构
[1] Univ Pisa, Dept Clin & Expt Med, I-56126 Pisa, Italy
[2] Hop La Pitie Salpetriere, Inst Memory & Alzheimers Dis IM2A, Brain & Spine Inst ICM, UMR S 1127,Dept Neurol, F-75651 Paris, France
[3] Pierre & Marie Curie Univ, Sorbonne Univ, Paris VI, F-75005 Paris, France
[4] AXA Res Fund, F-75005 Paris, France
[5] Pierre & Marie Curie Univ Chair, F-75005 Paris, France
[6] Hop La Pitie Salpetriere, IHU A ICM Paris Inst Translat Neurosci, F-75651 Paris, France
[7] Univ Roma Tor Vergata, Dept Biomed & Prevent, Fac Med, I-00173 Rome, Italy
[8] San Raffaele Cassino Nursing Home, I-03043 Cassino, FR, Italy
[9] Massachusetts Gen Hosp, Dept Radiol, Athinoula A Martinos Ctr Biomed Imaging, Charlestown, MA 02129 USA
[10] Harvard Med Sch, Charlestown, MA 02129 USA
关键词
ALZHEIMERS-DISEASE; DIAGNOSTIC-CRITERIA; DEMENTIA;
D O I
10.1016/j.jshs.2016.08.007
中图分类号
F [经济];
学科分类号
02 ;
摘要
引用
收藏
页码:383 / 387
页数:5
相关论文
共 50 条
  • [31] Biological and analytical variation of clinical biomarker testing: Implications for biomarker-guided therapy
    Wu A.H.B.
    Current Heart Failure Reports, 2013, 10 (4) : 434 - 440
  • [32] Biomonitoring and Biomarker-Guided Therapy The Next Step in Heart Failure and Biomarker Research
    Maisel, Alan
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2011, 58 (18) : 1890 - 1892
  • [33] Biomarker-guided neuromodulation aids memory in traumatic brain injury
    Kahana, Michael J.
    Ezzyat, Youssef
    Wanda, Paul A.
    Solomon, Ethan A.
    Adamovich-Zeitlin, Richard
    Lega, Bradley C.
    Jobst, Barbara C.
    Gross, Robert E.
    Ding, Kan
    Diaz-Arrastia, Ramon R.
    BRAIN STIMULATION, 2023, 16 (04) : 1086 - 1093
  • [34] Biomarker-Guided Strategy for Treatment of Autism Spectrum Disorder (ASD)
    Liu, Hua
    Talalay, Paul
    Fahey, Jed W.
    CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2016, 15 (05) : 602 - 613
  • [35] Biomarker-guided antibiotic cessation in sepsis: evidence and future challenges
    Claxton, Andrew N.
    Dark, Paul M.
    BRITISH JOURNAL OF HOSPITAL MEDICINE, 2018, 79 (03) : 136 - 141
  • [36] Biomarker-Guided Therapies in Heart Failure: A Forum for Unified Strategies
    Fiuzat, Mona
    O'Connor, Christopher M.
    Gueyffier, Francois
    Mascette, Alice M.
    Geller, Nancy L.
    Mebazaa, Alexandre
    Voors, Adriaan A.
    Adams, Kirkwood F.
    Pina, Ileana L.
    Neyses, Ludwig
    Muntendam, Pieter
    Felker, G. Michael
    Pitt, Bertram
    Zannad, Faiez
    Bristow, Michael R.
    JOURNAL OF CARDIAC FAILURE, 2013, 19 (08) : 592 - 599
  • [37] Are We Ready for Biomarker-Guided Immune Modulation in Critical Care?
    Leligdowicz, Aleksandra
    CRITICAL CARE MEDICINE, 2023, 51 (12) : 1827 - 1829
  • [38] Biomarker-Guided Antibiotic Duration for Hospitalized Patients With Suspected Sepsis
    Dark, Paul
    Hossain, Anower
    Mcauley, Daniel F.
    Brealey, David
    Carlson, Gordon
    Clayton, Jonathan C.
    Felton, Timothy W.
    Ghuman, Belinder K.
    Gordon, Anthony C.
    Hellyer, Thomas P.
    Lone, Nazir I.
    Manazar, Uzma
    Richards, Gillian
    Mccullagh, Iain J.
    Mcmullan, Ronan
    Mcnamee, James J.
    Mcneil, Hannah C.
    Mouncey, Paul R.
    Naisbitt, Micheal J.
    Parker, Robert J.
    Poole, Ruth L.
    Rostron, Anthony J.
    Singer, Mervyn
    Stevenson, Matt D.
    Walsh, Tim S.
    Welters, Ingeborg D.
    Whitehouse, Tony
    Whiteley, Simon
    Wilson, Peter
    Young, Keith K.
    Perkins, Gavin D.
    Lall, Ranjit
    ADAPT Sepsis Collaborators
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2024,
  • [39] Biomarker-guided translation of brain imaging into disease pathway models
    Erfan Younesi
    Martin Hofmann-Apitius
    Scientific Reports, 3
  • [40] Site-agnostic biomarker-guided oncology drug development
    Jorgensen, Jan Trost
    EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2020, 20 (06) : 583 - 592